NEOG Stock Analysis: Buy, Sell, or Hold?
NEOG - Neogen Corp
$10.22
0.01 (0.10%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Apr 01, 2026
Get Alerted When NEOG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NEOG shows positive signals but monitor for confirmation. Market pricing in 12.2% growth. Moderate conviction.
💡 BUY OPPORTUNITY: NEOG shows positive signals but monitor for confirmation. Market pricing in 12.2% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.25
Based on -2.7% avg growth
INTRINSIC VALUE TODAY
$3.88
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NEOG is currently trading at $10.22, which is considered extended relative to its 30-day fair value range of $7.39 to $10.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 31.6) compared to its historical average (22.3). At these levels, the market is pricing in 12.2% annual earnings growth.
Technical Outlook: Technically, NEOG is in a strong uptrend. The price is approaching resistance at $10.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NEOG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.67 (+14.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEOG is in a strong uptrend. The price is approaching resistance at $10.44. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: NEOG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.67 (+14.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$7.39 -
$10.00
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.9%
Protect Your Profits
NEOG is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($11.67)
- BULLISH: Expecting earnings turnaround to 12.2% growth with -2.8% revenue growth
Fair Price Analysis
30-Day Fair Range
$7.39 -
$10.00
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$8.93
Resistance Level
$10.44
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
31.58
Wall Street Target
$11.67
(+14.3%)
Revenue Growth (YoY)
-2.8%
Earnings Growth (YoY)
-85.6%
Profit Margin
-68.5%
Valuation Premium vs History
+12.2% premium
PE vs Historical
31.6 vs 22.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+12.2%
(market-implied from PE analysis)
1-Year Target
$11.46
(+12%)
2-Year Target
$12.85
(+26%)
3-Year Target
$14.42
(+41%)
3-Yr Target (if PE normalizes)
(PE: 32→22)
PE COMPRESSION
$10.18
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.6, Growth: -9.4%)
$7.60
(+-26%)
Base:
(SPY PE: 22.3, Growth: -9.4%)
$5.37
(-47%)
Bear:
(PE: 19.0, Growth: -9.4%)
$4.56
(-55%)
Last updated: January 31, 2026 2:58 PM ET
Data refreshes hourly during market hours. Next update: 3:58 PM
Data refreshes hourly during market hours. Next update: 3:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEOG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced NEOG Option Strategies
Professional options setups generated by AI based on today's NEOG price and gamma walls.
